These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24837058)

  • 1. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.
    Buchy L; Perkins D; Woods SW; Liu L; Addington J
    Schizophr Res; 2014 Jul; 156(2-3):277-80. PubMed ID: 24837058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use in individuals at clinical high risk of psychosis.
    Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Heinssen R; Bearden CE; Mathalon D; Addington J
    Psychol Med; 2015 Aug; 45(11):2275-84. PubMed ID: 25727300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis.
    Santesteban-Echarri O; Liu L; Miller M; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
    Schizophr Res; 2022 Oct; 248():114-121. PubMed ID: 36030758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.
    Auther AM; Cadenhead KS; Carrión RE; Addington J; Bearden CE; Cannon TD; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Cornblatt BA
    Acta Psychiatr Scand; 2015 Jul; 132(1):60-8. PubMed ID: 25572323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use in clinical high risk for psychosis: a review of the literature.
    Addington J; Case N; Saleem MM; Auther AM; Cornblatt BA; Cadenhead KS
    Early Interv Psychiatry; 2014 May; 8(2):104-12. PubMed ID: 24224849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid diagnoses for youth at clinical high risk of psychosis.
    Addington J; Piskulic D; Liu L; Lockwood J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Bearden CE; Mathalon DH; Woods SW
    Schizophr Res; 2017 Dec; 190():90-95. PubMed ID: 28372906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis.
    van der Meer FJ; Velthorst E; Meijer CJ; Machielsen MW; de Haan L
    Curr Pharm Des; 2012; 18(32):5036-44. PubMed ID: 22716158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
    Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
    J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.
    Cannon TD; Cadenhead K; Cornblatt B; Woods SW; Addington J; Walker E; Seidman LJ; Perkins D; Tsuang M; McGlashan T; Heinssen R
    Arch Gen Psychiatry; 2008 Jan; 65(1):28-37. PubMed ID: 18180426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of a family history of psychosis for youth at clinical high risk of psychosis.
    Georgopoulos G; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):251-256. PubMed ID: 28792113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use in youth at risk for psychosis.
    Carney R; Yung AR; Amminger GP; Bradshaw T; Glozier N; Hermens DF; Hickie IB; Killackey E; McGorry P; Pantelis C; Wood SJ; Purcell R
    Schizophr Res; 2017 Mar; 181():23-29. PubMed ID: 27590573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.
    Compton MT; Kelley ME; Ramsay CE; Pringle M; Goulding SM; Esterberg ML; Stewart T; Walker EF
    Am J Psychiatry; 2009 Nov; 166(11):1251-7. PubMed ID: 19797432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis.
    Amir CM; Kapler S; Hoftman GD; Kushan L; Zinberg J; Cadenhead KS; Kennedy L; Cornblatt BA; Keshavan M; Mathalon DH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J; Bearden CE
    Front Psychiatry; 2023; 14():1143315. PubMed ID: 37151981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis.
    Bearden CE; Wu KN; Caplan R; Cannon TD
    J Am Acad Child Adolesc Psychiatry; 2011 Jul; 50(7):669-80. PubMed ID: 21703494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.